Zepp Health Statistics
Total Valuation
Zepp Health has a market cap or net worth of $40.81 million. The enterprise value is $68.05 million.
Important Dates
The next confirmed earnings date is Monday, May 19, 2025, after market close.
| Earnings Date | May 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Zepp Health has 14.37 million shares outstanding. The number of shares has increased by 6.47% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 14.37M |
| Shares Change (YoY) | +6.47% |
| Shares Change (QoQ) | -0.45% |
| Owned by Insiders (%) | 35.37% |
| Owned by Institutions (%) | 14.39% |
| Float | 6.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.22 |
| Forward PS | n/a |
| PB Ratio | 0.15 |
| P/TBV Ratio | 0.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.29, with a Debt / Equity ratio of 0.48.
| Current Ratio | 1.29 |
| Quick Ratio | 0.88 |
| Debt / Equity | 0.48 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.51 |
Financial Efficiency
Return on equity (ROE) is -25.04% and return on invested capital (ROIC) is -6.91%.
| Return on Equity (ROE) | -25.04% |
| Return on Assets (ROA) | -5.07% |
| Return on Invested Capital (ROIC) | -6.91% |
| Return on Capital Employed (ROCE) | -14.18% |
| Revenue Per Employee | $238,697 |
| Profits Per Employee | -$98,997 |
| Employee Count | 765 |
| Asset Turnover | 0.31 |
| Inventory Turnover | 1.59 |
Taxes
In the past 12 months, Zepp Health has paid $13.69 million in taxes.
| Income Tax | 13.69M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.43% in the last 52 weeks. The beta is 0.80, so Zepp Health's price volatility has been lower than the market average.
| Beta (5Y) | 0.80 |
| 52-Week Price Change | -7.43% |
| 50-Day Moving Average | 2.83 |
| 200-Day Moving Average | 2.98 |
| Relative Strength Index (RSI) | 63.14 |
| Average Volume (20 Days) | 14,975 |
Short Selling Information
| Short Interest | 4,498 |
| Short Previous Month | 4,887 |
| Short % of Shares Out | 0.07% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.21 |
Income Statement
In the last 12 months, Zepp Health had revenue of $182.60 million and -$75.73 million in losses. Loss per share was -$4.68.
| Revenue | 182.60M |
| Gross Profit | 70.23M |
| Operating Income | -47.25M |
| Pretax Income | -23.90M |
| Net Income | -75.73M |
| EBITDA | -42.23M |
| EBIT | -47.25M |
| Loss Per Share | -$4.68 |
Full Income StatementBalance Sheet
The company has $92.07 million in cash and $120.46 million in debt, giving a net cash position of -$28.39 million or -$1.98 per share.
| Cash & Cash Equivalents | 92.07M |
| Total Debt | 120.46M |
| Net Cash | -28.39M |
| Net Cash Per Share | -$1.98 |
| Equity (Book Value) | 252.73M |
| Book Value Per Share | 17.35 |
| Working Capital | 56.20M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$24.39 million and capital expenditures -$1.40 million, giving a free cash flow of -$25.80 million.
| Operating Cash Flow | -24.39M |
| Capital Expenditures | -1.40M |
| Free Cash Flow | -25.80M |
| FCF Per Share | -$1.80 |
Full Cash Flow StatementMargins
Gross margin is 38.46%, with operating and profit margins of -25.88% and -41.47%.
| Gross Margin | 38.46% |
| Operating Margin | -25.88% |
| Pretax Margin | -34.02% |
| Profit Margin | -41.47% |
| EBITDA Margin | -23.13% |
| EBIT Margin | -25.88% |
| FCF Margin | n/a |